June 6, 2018 by Chain Drug Review
Aetna, CVS Health, CVS Health-Aetna, David Denton, Dr. Alan M. Lotvin, Dr. Harold Paz, Dr. Troyen Brennan, Jon Roberts, Jr., Karen Lynch, Larry Merlo, Lisa Bisaccia, Mark Bertolini, Meg McCarthy, Richard di Benedetto, Rick Jelinek, Shawn Guertin, Steven Kelmar, Thomas Moriarty, Thomas Sabatino
Business, Pharmacy, Retail News
WOONSOCKET, R.I. — CVS Health has announced the management team that, following the close of the Aetna acquisition, will lead the combined company into the future. Aetna will operate as a stand-alone business unit within the CVS Health enterprise following the close and will be led by members of its current management team. In addition,
March 13, 2018 by Chain Drug Review
Aetna, Amazon, Berskhire Hathaway, Cigna, CVS Health, CVS-Aetna merger, Express Scripts, JPMorgan Chase, Larry Merlo, Mark Bertolini, UnitedHealth Group
Business, Featured Articles, Leading Headlines, Pharmacy, Retail News
WOONSOCKET, R.I. — Shareholders of CVS Health voted overwhelmingly to approve the company’s $69 billion deal to acquire health insurer Aetna Inc. CVS said that in a special stockholders meeting on Tuesday, more than 98% of shares were voted in favor of the CVS-Aetna merger agreement, which was announced in early December. Also at a
December 11, 2017 by Bill Schiffner
Aetna, Amazon, Brian Tanquilut, CVS Health, CVS Pharmacy, CVS-Aetna merger, Jefferies, Larry Merlo, Mark Bertolini, MinuteClinic
2017, Issue 12-11-2017, Issues, News
WOONSOCKET, R.I. — CVS Health plans to acquire health insurer Aetna for roughly $69 billion in a first-of-its kind deal aimed at fending off challenges in retail and health care. The landmark CVS-Aetna merger deal comes at time when insurers are under pressure to lower medical costs, and retailers are under attack from new competitors,
December 3, 2017 by Chain Drug Review
Aetna, CVS Caremark, CVS Health, CVS Pharmacy, CVS-Aetna merger, Larry Merlo, Mark Bertolini, MinuteClinic
Business, Featured Articles, Leading Headlines, Retail News
WOONSOCKET, R.I., and HARTFORD, Conn. — Following mounting speculation over the past month, CVS Health has unveiled a cash-and stock-deal to acquire health insurer Aetna Inc. for $69 billion. CVS and Aetna said Sunday evening that under the merger pact, Aetna shareholders will receive about $207 per share, including $145 in cash and 0.8378 CVS
November 6, 2017 by Bill Schiffner
Adam Fein, Aetna, Amazon, CVS Caremark, CVS Health, CVS Pharmacy, CVS-Aetna deal, Humana, Larry Merlo, Mark Bertolini, MinuteClinic, OptumRx, Pembroke Consulting, UnitedHealth
2017, Issue 11-06-2017, Issues, News
WOONSOCKET, R.I. — At presstime The Wall Street Journal along with other news agencies reported that CVS Health will offer more than $200 per share, or about $66 billion, to purchase the health insurance giant Aetna Inc. Anonymous sources cited by WSJ originated the story about a potential CVS-Aetna deal. The possible transaction comes as
February 27, 2017 by Greg Jacobson and Chain Drug Review
ACA, ACA exchanges, Aetna, Affordable Care Act, Health and Human Services, health insurance exchanges, Humana, Mark Bertolini, Obamacare, Tom Price, Trump administration
2017, Issue 02-27-2017, Issues, News
WASHINGTON — Humana Inc.’s decision to pull out of the health insurance exchanges created by the Affordable Care Act threatens to cripple Obamacare before Republican lawmakers bent on its repeal can cobble together a replacement. The Humana decision came one day before the Trump administration issued a proposed rule that attempts to offer insurers more
February 21, 2017 by Greg Jacobson and Chain Drug Review
ACA, Aetna, Affordable Care Act, health insurance exchanges, Humana, Mark Bertolini, Obamacare, Tom Price
Featured Articles, Leading Headlines, Pharmacy, Retail News
WASHINGTON — Humana Inc.’s decision to pull out of the health insurance exchanges created by the Affordable Care Act threatens to cripple Obamacare before Republican lawmakers bent on its repeal can cobble together a replacement. The Humana decision came one day before the Trump White House issued a proposed rule that attempts to offer insurers
February 14, 2017 by Chain Drug Review
Aetna, Affordable Care Act, Anthem, Cigna, health insurance, Humana, Joseph Swedish, Mark Bertolini
Business, Leading Headlines, Pharmacy, Retail News
HARTFORD, Conn., and LOUISVILLE, Ky. — After being blocked by a federal court, Aetna Inc. and Humana Inc. have decided to terminate their $37 billion merger deal. The health insurance giants said Tuesday that, with the move, Aetna will pay Humana a $1 billion breakup fee. Aetna said it also has ended its agreement to
February 6, 2017 by Mark Baumgartner and Chain Drug Review
Aetna, Aetna-Humana merger, Affordable Care Act, Anthem-Cigna merger, Bruce Broussard, health insurers, Humana, Mark Bertolini, Medicare Advantage
2017, Issue 02-06-2017, Issues, News
WASHINGTON — A federal judge last month temporarily blocked Aetna Inc.’s proposed acquisition of Humana Inc. The move stemmed from a ruling on a lawsuit brought last year by the Justice Department to prevent the health insurers from merging on the grounds that the deal would produce higher prices for consumers and fewer services for
September 6, 2016 by Geoff Walden and Chain Drug Review
ACA enrollment, Aetna, Affordable Care Act, Drew Altman, health insurance exchanges, health insurance marketplaces, Humana, Kaiser Family Foundation, Marilyn Tavenner, Mark Bertolini, UnitedHealth Group
Issue 09-12-2016, Leading Headlines, News, Pharmacy, Retail News
WASHINGTON — The pullback of health insurance companies from the Affordable Care Act has focused a harsh light on President Obama’s signature legislative achievement. Most recently, Aetna Inc. decided to drop out of ACA health insurance exchanges in 11 states with about two-thirds of the 778 counties where it now offers coverage. It will continue
August 10, 2015 by Geoff Walden and Chain Drug Review
Aetna, Affordable Care Act, Anthem, chain drug retailers, chain pharmacies, Cigna, health insurance industry, health insurer consolidation, health insurer megadeals, Humana, Joseph Swedish, Mark Bertolini, Medicaid business, Medicare Advantage plans
2015, Issue 08-10-2015, Issues, News
NEW YORK — Chain drug retailers have gotten used to dealing with fewer, and larger, drug makers, wholesalers and pharmacy benefit managers over the years. Retailers themselves have also consolidated, and now a merger wave has washed over the health insurance industry. While acquisitions in other sectors have been driven by the pursuit of economies